The effect of homocysteine-lowering with B-vitamins on osteoporotic fractures in patients with cerebrovascular disease: substudy of VITATOPS, a randomised placebo-controlled trial (Q34978212)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	The effect of homocysteine-lowering with B-vitamins on osteoporotic fractures in patients with cerebrovascular disease: substudy of VITATOPS, a randomised placebo-controlled trial	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

The effect of homocysteine-lowering with B-vitamins on osteoporotic fractures in patients with cerebrovascular disease: substudy of VITATOPS, a randomised placebo-controlled trial (English)

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

0 references

0 references

0 references

cerebrovascular disease

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Graeme J. Hankey

object named as

Graeme J Hankey

4

0 references

John W. Eikelboom

3

object named as

John W Eikelboom

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

Christopher S. Chen

5

object named as

Christopher Chen

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

author name string

John Gommans

1

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

Qilong Yi

2

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

Helen Rodgers

6

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

VITATOPS trial study group

7

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

publication date

3 September 2013

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

13

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

88

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

Rationale and design of the B-PROOF study, a randomized controlled trial on the effect of supplemental intake of vitamin B12 and folic acid on fracture incidence

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3848681

8 July 2018

B vitamins in patients with recent transient ischaemic attack or stroke in the VITAmins TO Prevent Stroke (VITATOPS) trial: a randomised, double-blind, parallel, placebo-controlled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3848681

8 July 2018

The complex mutual connection between stroke and bone health

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3848681

8 July 2018

Predicting risk of osteoporotic fracture in men and women in England and Wales: prospective derivation and validation of QFractureScores

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3848681

8 July 2018

Bone tissue and hyperhomocysteinemia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3848681

8 July 2018

Plasma B vitamins, homocysteine, and their relation with bone loss and hip fracture in elderly men and women

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3848681

8 July 2018

The role of hyperhomocysteinemia as well as folate, vitamin B(6) and B(12) deficiencies in osteoporosis: a systematic review

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3848681

8 July 2018

Incidence and economic burden of osteoporosis-related fractures in the United States, 2005-2025.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3848681

8 July 2018

Homocysteine lowering with folic acid and B vitamins in vascular disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3848681

8 July 2018

Dose-dependent effects of folic acid on blood concentrations of homocysteine: a meta-analysis of the randomized trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3848681

8 July 2018

Homocysteine--a newly recognised risk factor for osteoporosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3848681

8 July 2018

Effect of folate and mecobalamin on hip fractures in patients with stroke: a randomized controlled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3848681

8 July 2018

Homocysteine as a predictive factor for hip fracture in older persons

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3848681

8 July 2018

Homocysteine levels and the risk of osteoporotic fracture

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3848681

8 July 2018

DACH-LIGA homocystein (german, austrian and swiss homocysteine society): consensus paper on the rational clinical use of homocysteine, folic acid and B-vitamins in cardiovascular and thrombotic diseases: guidelines and recommendations

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3848681

8 July 2018

Adverse outcomes of osteoporotic fractures in the general population

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3848681

8 July 2018

The VITATOPS (Vitamins to Prevent Stroke) Trial: rationale and design of an international, large, simple, randomised trial of homocysteine-lowering multivitamin therapy in patients with recent transient ischaemic attack or stroke

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3848681

8 July 2018

Osteoporosis prevention, diagnosis, and therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3848681

8 July 2018

Homocysteine and osteoporotic fractures--culprit or bystander?

1 reference

https://api.crossref.org/works/10.1186%2F1471-2318-13-88

21 January 2018

Homocysteine and vitamin B12 status relate to bone turnover markers, broadband ultrasound attenuation, and fractures in healthy elderly people.

1 reference

https://api.crossref.org/works/10.1186%2F1471-2318-13-88

21 January 2018

Folic acid and vitamin B(12) supplementation lowers plasma homocysteine but has no effect on serum bone turnover markers in elderly women: a randomized, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1186%2F1471-2318-13-88

21 January 2018

Randomized clinical trial of homocysteine level lowering therapy and fractures

1 reference

https://api.crossref.org/works/10.1186%2F1471-2318-13-88

21 January 2018

Homocysteine and fracture prevention

1 reference

https://api.crossref.org/works/10.1186%2F1471-2318-13-88

21 January 2018

The effect of B-vitamins on biochemical bone turnover markers and bone mineral density in osteoporotic patients: a 1-year double blind placebo controlled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3848681

26 October 2018

Lowering homocysteine with B vitamins has no effect on biomarkers of bone turnover in older persons: a 2-y randomized controlled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3848681

26 October 2018

Folate supplementation does not affect biochemical markers of bone turnover.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3848681

26 October 2018

Epidemiology and direct medical costs of osteoporotic fractures in men and women in Switzerland

1 reference

https://pubmed.ncbi.nlm.nih.gov/24004645

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Associations between homocysteine, bone turnover, BMD, mortality, and fracture risk in elderly women

1 reference

https://pubmed.ncbi.nlm.nih.gov/24004645

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Plasma homocysteine, folate, and vitamin B 12 and the risk of hip fracture: the hordaland homocysteine study

1 reference

https://pubmed.ncbi.nlm.nih.gov/24004645

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Vitamin B supplements for prevention of stroke

1 reference

https://pubmed.ncbi.nlm.nih.gov/24004645

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1186/1471-2318-13-88

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

Dimensions Publication ID

0 references

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34978212&oldid=2197102208"